tirzepatide mash fda Nearly 62% achieve resolution without worsening of fibrosis with Eli Lilly touts tirzepatide's midstage

Compounded semaglutide may be safe

Discover what to expect and how to make your weekly shot easier

Patients lose avg 9.6 lbs in 30 days

GLP-1 (glucagon-like peptide-1) receptor agonists originally developed for metabolic health are showing remarkable promise in the treatment of alcohol use disorder

The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

Five Russian brands have taken over the market after the drug largely vanished from pharmacy shelves due to the exit of Western companies in response to Moscows full-scale invasion of Ukraine in 2022